Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Yoshimoto

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Annals of Surgical Oncology|November 19, 2013
Association of a genetic variant of CYP19A1 with multicentric development of lung adenocarcinomasKoei Ikeda, Kenji Shiraishi, Ayami Eguchi, et al.
Thoracic Cancer|September 9, 2024
Comparison of survivals between sublobar resection and lobar resection for patients with clinical stage I non-small cell lung cancer and interstitial lung disease: a propensity score matching analysisRyohei Matsushima, Kosuke Fujino, Yamato Motooka, et al.
Cancer Science|November 20, 2010
Peptides derived from human insulin-like growth factor-II mRNA binding protein 3 can induce human leukocyte antigen-A2-restricted cytotoxic T lymphocytes reactive to cancer cellsYusuke Tomita, Michiko Harao, Satoru Senju, et al.
Surgery Today|July 25, 2015
Novel approach to pleurodesis with 50 % glucose for air leakage after lung resection or pneumothoraxKosuke Fujino, Yamato Motooka, Takamasa Koga, et al.
Journal of Thoracic Disease|December 11, 2025
Phase 2 feasibility study of adjuvant chemotherapy with cisplatin (CDDP) and TS-1, followed by alternate-day TS-1 maintenance therapy, in patients with completely resected pathological stage II-IIIA non-small cell lung cancerKosuke Fujino, Riichiroh Maruyama, Takashi Marutsuka, et al.
Trials|September 17, 2017
A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trialHideo Saka, Chiyoe Kitagawa, Yukito Ichinose, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 15, 2017
A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303Hisashi Saji, Takahiko Ueno, Hiroshige Nakamura, et al.
Interactive Cardiovascular and Thoracic Surgery|May 27, 2016
Early and late recurrence after intentional limited resection for cT1aN0M0, non-small cell lung cancer: from a multi-institutional, retrospective analysis in JapanYuki Matsumura, Motoki Yano, Junji Yoshida, et al.
World Journal of Surgery|July 2, 2016
The Outcomes of a Limited Resection for Non-Small Cell Lung Cancer Based on Differences in PathologyMotoki Yano, Junji Yoshida, Terumoto Koike, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 5, 2014
Survival of 1737 lobectomy-tolerable patients who underwent limited resection for cStage IA non-small-cell lung cancerMotoki Yano, Junji Yoshida, Terumoto Koike, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Annals of Surgical Oncology|November 19, 2013
Association of a genetic variant of CYP19A1 with multicentric development of lung adenocarcinomasKoei Ikeda, Kenji Shiraishi, Ayami Eguchi, et al.
Thoracic Cancer|September 9, 2024
Comparison of survivals between sublobar resection and lobar resection for patients with clinical stage I non-small cell lung cancer and interstitial lung disease: a propensity score matching analysisRyohei Matsushima, Kosuke Fujino, Yamato Motooka, et al.
Cancer Science|November 20, 2010
Peptides derived from human insulin-like growth factor-II mRNA binding protein 3 can induce human leukocyte antigen-A2-restricted cytotoxic T lymphocytes reactive to cancer cellsYusuke Tomita, Michiko Harao, Satoru Senju, et al.
Surgery Today|July 25, 2015
Novel approach to pleurodesis with 50 % glucose for air leakage after lung resection or pneumothoraxKosuke Fujino, Yamato Motooka, Takamasa Koga, et al.
Journal of Thoracic Disease|December 11, 2025
Phase 2 feasibility study of adjuvant chemotherapy with cisplatin (CDDP) and TS-1, followed by alternate-day TS-1 maintenance therapy, in patients with completely resected pathological stage II-IIIA non-small cell lung cancerKosuke Fujino, Riichiroh Maruyama, Takashi Marutsuka, et al.
Trials|September 17, 2017
A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trialHideo Saka, Chiyoe Kitagawa, Yukito Ichinose, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 15, 2017
A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303Hisashi Saji, Takahiko Ueno, Hiroshige Nakamura, et al.
Interactive Cardiovascular and Thoracic Surgery|May 27, 2016
Early and late recurrence after intentional limited resection for cT1aN0M0, non-small cell lung cancer: from a multi-institutional, retrospective analysis in JapanYuki Matsumura, Motoki Yano, Junji Yoshida, et al.
World Journal of Surgery|July 2, 2016
The Outcomes of a Limited Resection for Non-Small Cell Lung Cancer Based on Differences in PathologyMotoki Yano, Junji Yoshida, Terumoto Koike, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 5, 2014
Survival of 1737 lobectomy-tolerable patients who underwent limited resection for cStage IA non-small-cell lung cancerMotoki Yano, Junji Yoshida, Terumoto Koike, et al.
Pageof 4